These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28356286)

  • 1. Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation.
    Park JH; Jang HR; Kim DH; Kwon GY; Lee JE; Huh W; Choi SJ; Oh W; Oh HY; Kim YG
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F984-F996. PubMed ID: 28356286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on the development of renal ischemia-reperfusion injury in mice.
    Jang HR; Park JH; Kwon GY; Lee JE; Huh W; Jin HJ; Choi SJ; Oh W; Oh HY; Kim YG
    Am J Physiol Renal Physiol; 2014 Nov; 307(10):F1149-61. PubMed ID: 25143451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
    Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
    Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway.
    Bai M; Zhang L; Fu B; Bai J; Zhang Y; Cai G; Bai X; Feng Z; Sun S; Chen X
    Kidney Int; 2018 Apr; 93(4):814-825. PubMed ID: 29132705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
    Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
    Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury.
    Guo Q; Wang J
    Immunopharmacol Immunotoxicol; 2018 Apr; 40(2):168-172. PubMed ID: 29355065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protects against ischemia/reperfusion-induced acute kidney injury.
    Tsuda H; Yamahara K; Otani K; Okumi M; Yazawa K; Kaimori JY; Taguchi A; Kangawa K; Ikeda T; Takahara S; Isaka Y
    Cell Transplant; 2014; 23(7):889-99. PubMed ID: 23562186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor.
    Kim H; Lee H; Lee G; Jang H; Kim SS; Yoon H; Kang GH; Hwang DS; Kim SK; Chung HS; Bae H
    Kidney Int; 2015 Sep; 88(3):550-9. PubMed ID: 25993317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF-modified human embryonic mesenchymal stem cell implantation enhances protection against cisplatin-induced acute kidney injury.
    Yuan L; Wu MJ; Sun HY; Xiong J; Zhang Y; Liu CY; Fu LL; Liu DM; Liu HQ; Mei CL
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F207-18. PubMed ID: 20943766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats.
    Kim JH; Park DJ; Yun JC; Jung MH; Yeo HD; Kim HJ; Kim DW; Yang JI; Lee GW; Jeong SH; Roh GS; Chang SH
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1141-50. PubMed ID: 22205231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal-like progenitors derived from human embryonic stem cells promote recovery from acute kidney injury via paracrine actions.
    Luo J; Zhao X; Tan Z; Su Z; Meng F; Zhang M
    Cytotherapy; 2013 Jun; 15(6):649-62. PubMed ID: 23415919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
    Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.
    Burks SR; Nguyen BA; Tebebi PA; Kim SJ; Bresler MN; Ziadloo A; Street JM; Yuen PS; Star RA; Frank JA
    Stem Cells; 2015 Apr; 33(4):1241-53. PubMed ID: 25640064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
    Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
    PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.
    Sherif IO; Al-Mutabagani LA; Alnakhli AM; Sobh MA; Mohammed HE
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1572-9. PubMed ID: 25825359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stem Cells: a Promising Therapeutic Tool for Acute Kidney Injury.
    Selim RE; Ahmed HH; Abd-Allah SH; Sabry GM; Hassan RE; Khalil WKB; Abouhashem NS
    Appl Biochem Biotechnol; 2019 Sep; 189(1):284-304. PubMed ID: 30976980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.